TRACON Pharmaceuticals to Present at the 15th Annual Needham Healthcare Conference
Apr 05, 2016 20:05 pm UTC| Business
SAN DIEGO, April 05, 2016 -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, wet age-related...
Johnson Outdoors Acquires Assets of Northport Systems
Apr 05, 2016 20:03 pm UTC| Business
RACINE, Wis., April 05, 2016 -- Johnson Outdoors Inc. (NASDAQ:JOUT) today announced the acquisition of the key assets of Northport Systems, Inc., specialists in the development and application of unique digital...
Bermuda is different: BDA responds to Panama Papers
Apr 05, 2016 20:02 pm UTC| Business
HAMILTON, Bermuda, April 05, 2016 -- Some of the recent reporting on the “Panama Papers” perpetuates the myth that all offshore financial centres are the same. The fact is: Bermuda is different. While there may be...
The Shelter Pet Project to Ring The Nasdaq Stock Market Closing Bell
Apr 05, 2016 20:02 pm UTC| Business
ADVISORY, April 05, 2016 -- What:Representatives from The Shelter Pet Project will visit the Nasdaq MarketSite in Times Square. The Shelter Pet Project, a collaborative effort between the Ad Council and two leading...
Pernix Therapeutics to Present at Needham & Company’s 15th Annual Healthcare Conference
Apr 05, 2016 20:01 pm UTC| Business
MORRISTOWN, N.J., April 05, 2016 -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman and Chief Executive Officer, and Sanjay Patel, Chief...
KemPharm to Present at the Needham & Company’s 15th Annual Healthcare Conference in New York, NY
Apr 05, 2016 20:01 pm UTC| Business
CORALVILLE, Iowa, April 05, 2016 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its president...
Fate Therapeutics to Present at the Needham & Company 15th Annual Healthcare Conference
Apr 05, 2016 20:01 pm UTC| Business
SAN DIEGO, April 05, 2016 -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that...